Cytosorbents Cor (CTSO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2008 | 03-2008 | 12-2007 | 09-2007 | 06-2007 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,500 | -640 | -3,350 | -2,750 | -2,160 |
| Depreciation Amortization | 50 | 20 | 190 | 140 | 90 |
| Other Working Capital | 260 | 240 | -310 | -260 | 240 |
| Other Operating Activity | 310 | 120 | 850 | 810 | 460 |
| Operating Cash Flow | $-880 | $-260 | $-2,620 | $-2,060 | $-1,370 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1 | -1 | -20 | -20 | -20 |
| Other Investing Activity | -9 | -4 | -10 | -10 | -10 |
| Investing Cash Flow | $-10 | $-5 | $-30 | $-30 | $-30 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 4,280 | 100 | 0 | 0 | 0 |
| Financing Cash Flow | $4,280 | $100 | $0 | $0 | $0 |
| Beginning Cash Position | 210 | 210 | 2,870 | 2,870 | 2,870 |
| End Cash Position | 3,590 | 40 | 210 | 770 | 1,460 |
| Net Cash Flow | $3,380 | $-160 | $-2,660 | $-2,090 | $-1,400 |
| Free Cash Flow | |||||
| Operating Cash Flow | -880 | -260 | -2,620 | -2,060 | -1,370 |
| Free Cash Flow | -880 | -260 | -2,620 | -2,060 | -1,370 |